Fengjun Cao
Hubei University of Medicine(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics, Pancreatic and Hepatic Oncology Research, Epigenetics and DNA Methylation
Most-Cited Works
- → Pharmacokinetics of Anthraquinones from Medicinal Plants(2021)115 cited
- → APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases(2022)90 cited
- → The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review(2015)86 cited
- → Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis(2018)59 cited
- → Metformin therapy associated with survival benefit in lung cancer patients with diabetes(2016)57 cited
- → Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells(2019)51 cited
- → Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA(2019)45 cited
- → Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine(2016)43 cited
- → The expression of HDAC7 in cancerous gastric tissues is positively associated with distant metastasis and poor patient prognosis(2017)40 cited
- → Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer(2017)33 cited